MOMETASONE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 187 adverse event reports in the FDA FAERS database where MOMETASONE was used for Psoriasis.
Most Reported Side Effects for MOMETASONE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Asthma | 522 | 31.0% | 1 | 312 |
| Dyspnoea | 497 | 29.5% | 3 | 284 |
| Wheezing | 459 | 27.2% | 1 | 255 |
| Gastrooesophageal reflux disease | 406 | 24.1% | 0 | 277 |
| Therapeutic product effect incomplete | 400 | 23.7% | 1 | 248 |
| Drug ineffective | 318 | 18.9% | 3 | 54 |
| Sleep disorder due to a general medical condition | 318 | 18.9% | 1 | 238 |
| Cardiac disorder | 311 | 18.5% | 5 | 183 |
| Headache | 308 | 18.3% | 0 | 214 |
| Loss of personal independence in daily activities | 301 | 17.9% | 1 | 215 |
| Cough | 294 | 17.4% | 2 | 96 |
| Hypertension | 271 | 16.1% | 0 | 208 |
| Blood test abnormal | 245 | 14.5% | 0 | 203 |
| Rhinitis allergic | 232 | 13.8% | 0 | 180 |
| Burning sensation | 230 | 13.6% | 0 | 180 |
Other Indications for MOMETASONE
Product used for unknown indication (922)
Eczema (64)
Asthma (53)
Dermatitis atopic (44)
Seasonal allergy (23)
Migraine (21)
Rhinitis allergic (21)
Sinusitis (19)
Rhinitis (16)
Pruritus (15)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)